Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA gene therapy office director

Executive Summary

Center for Biologics Evaluation & Research's Office of Cellular, Tissue & Gene Therapies' new director is Celia Witten. She was previously head of the Center for Devices & Radiological Health's Division of General, Restorative & Neurological Devices. The gene therapy office had been headed by former Intronn COO Edward Otto, who joined in November (1"The Pink Sheet" Nov. 1, 2004, In Brief). Otto left "to pursue outside interests," the agency said. Witten assumed her new role March 7...

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts